ZYBT
Zhengye Biotechnology Holding Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.32
−1.69%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.37
From 52W high−83.55%
Volume21795.00
Market cap$39.16M
P/E (TTM)—
P/S (TTM)1.8x
Div yield—
Key dataNov 4, 2026
Open
$1.37
From 52W high
−83.55%
Volume
21795.00
Market cap
$39.16M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.9x
P/E (TTM)
—
RSI (14)
45.0
MomentumView details →
1D Return
−1.69%
YTD Return
+15.65%
SummaryUpdated Dec 1, 2025
Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) is a Chinese veterinary vaccine manufacturer that went public in January 2025. Founded in 2004 and headquartered in Jilin, China, the company has established itself as a specialized producer of vaccines for livestock and companion animals. Operating as a subsidiary of Securingium Holding Limited, Zhengye has built its business around serving China's large agricultural sector while also expanding into international markets including Vietnam, Pakistan, and Egypt.
Similar companies
Latest newsMore news →